Quick Summary
Covering the latest research from top Wall Street investment banks

2026 Midterm Election Outlook: Democrats Taking House Benefits Medicaid and Hospital Stocks

Institution
Bernstein
Date
20260612
Authors
Lance Wilkes
Company
FOOT LOCKER INC, Vance, HCA Healthcare, Block, Agilon Health, Centene, Cigna, CVS Health, Elevance Health, Humana, Molina Healthcare, UnitedHealth Group, Centene, Cigna, CVS Health, HCA Healthcare, Humana, UnitedHealth Group
Ticker
FL, OH, HCA, XYZ, AGL, CNC, CI, CVS, ELV, HUM, MOH, UNH
Industry
Apparel Retail, Medical Care Facilities, Software - Infrastructure, AI, AR, Healthcare Plans, Consumer Electronics, Healthcare Services
Rating
Mixed Ratings (Outperform/Market-Perform)
MixedMedium confidenceReiterateMedium-termThe report is optimistic about Medicaid-related names and hospitals, cautious about certain MCOs under the risk of restricted vertical integration, with overall ratings maintained but structurally divergent views.
AuthorsLance Wilkes
Target priceSee individual stock details
CoverageUnited States
Research firm divisions/subsidiariesBernstein Institutional Services LLC(Subsidiary/Legal Entity)

AI summary card

2026 Midterm Election Outlook: Democrats Taking House Benefits Medicaid and Hospital Stocks

Bernstein predicts that Democrats are likely to seize control of the House in the 2026 midterm elections, which will drive the restoration of Medicaid funding and ACA subsidies, benefiting Medicaid insurers like Centene and Molina, as well as hospitals like HCA; meanwhile, it anticipates that the policy focus for the 2028 election will shift toward restrictions on vertical integration.

Most covered names maintain Outperform ratings
US Healthcare Policy2026 Midterm ElectionsMedicaidVertical IntegrationHealth InsuranceHospital Sector
  • Predicts Democrats will win control of the House, while Senate results are uncertain (50/50).
  • Democratic control would aim to reverse the decline in Medicaid enrollment and restore enhanced ACA subsidies.
  • Medicaid Managed Care Organizations (e.g., CNC, MOH) and hospitals (e.g., HCA) are primary beneficiaries.
  • Medicare Advantage (MA) and PBM policy risks are relatively neutral in the medium term.
  • The 2028 election policy focus may shift to restricting vertical integration in healthcare (e.g., separating insurance from providers).
  • UnitedHealth (UNH) and Cigna (CI) are relatively more resilient in an environment with restricted vertical integration.

Report interpretation

Overview

This report provides an in-depth analysis of the potential impact of the 2026 US midterm elections on the healthcare services sector and forward-looking discussion on policy directions for the 2028 presidential election. The core conclusion is that Democrats are highly likely to regain control of the House, which will prompt a policy shift toward restoring Medicaid funding and Affordable Care Act (ACA) marketplace subsidies, thereby benefiting Medicaid-focused insurers and the hospital sector. In contrast, Medicare Advantage (MA) and Pharmacy Benefit Managers (PBMs) face lower policy risks. Looking further ahead, the central controversy of the 2028 election may shift from 'Medicare for All' to restrictions on vertical integration in the healthcare industry, which will have divergent impacts on giants with different business models.

Core views

Political Landscape and Midterm Election Outlook: Based on recent polls and prediction market data, the report believes there is a high probability that Democrats will seize control of the House in the 2026 midterms (prediction markets show a Democratic win rate of ~75%-82%), while the battle for Senate control is intense, with Republicans holding a slight edge but the outcome close to 50/50. Trump's current approval rating is approximately 40.2%, lower than during the same period of his first term, and historical data shows that the president's party typically loses House seats in midterm elections. Policy Impact and Investment Logic: If Democrats control the House, their primary policy goal will be to reverse the decline in Medicaid and Marketplace enrollment caused during the Republican era. Specific measures may include restoring enhanced ACA subsidies and delaying the implementation of certain provisions that cut Medicaid funding (such as parts of OBBBA). This constitutes a direct benefit for Medicaid-focused insurers like Centene (CNC) and Molina (MOH), as stable enrollment and improved risk pools help improve the Medical Loss Ratio (MLR). Meanwhile, the hospital sector (e.g., HCA Healthcare) will also benefit from reduced bad debt pressure due to fewer uninsured patients. The report notes that the market's reaction to this expectation is already reflected in the recent performance of Medicaid stocks, but hospital stocks have not yet fully priced this in. 2028 Election Outlook and Vertical Integration Risks: The report early on anticipated that the policy focus of the 2028 election would center on coverage, affordability, and vertical integration issues. The likelihood of 'Medicare for All' becoming formal policy has decreased, as Medicare Advantage now accounts for about 55% of Medicare enrollment, and public support for the ACA framework has rebounded. However, both parties may focus on restricting vertical integration in healthcare, particularly separating insurers from providers (such as physician groups, value-based care organizations) or PBMs from pharmacies. This 'antitrust'-style regulatory tendency could force large integrated companies to divest businesses. Divergent Impact on Individual Stocks: In a scenario with restricted vertical integration, UnitedHealth Group (UNH) and Cigna (CI) are considered relatively beneficial or resilient because their spun-off units (such as Optum Health, specialty pharmacy) are leaders in their respective fields and remain competitive independently. Conversely, Elevance Health (ELV) and CVS Health may suffer negative shocks because their value-based care businesses (such as Oak Street, CenterWell) or retail clinics heavily rely on synergies with insurance operations, losing cross-selling advantages and economies of scale upon separation.

Analysis framework

The report employs an analytical framework of 'political scenario analysis + policy transmission mechanism + individual stock fundamental mapping.' First, it constructs political scenario baselines for the midterm and 2028 elections using poll data and prediction market probabilities (e.g., Polymarket, Kalshi). Second, it analyzes the likely policy priorities after different parties control legislative bodies (e.g., Democrats focusing on Medicaid/ACA, Republicans focusing on cost control and deregulation) and assesses the direct impact of these policies on industry supply/demand and payer structures. Finally, it maps macro policy changes to the vulnerability or resilience of specific companies' business models, particularly conducting differentiated assessments for companies with varying degrees of vertical integration, thereby deriving investment ratings and target prices.

Methodology notes

  • Event Gaming and Behavioral FinanceEvent-driven analysis

    Policy Expectation Trading Driven by Election Cycles

    Using election prediction market data and polls to anticipate policy directions, thereby positioning assets ahead of time based on policy benefits or detriments. This method emphasizes the impact of market sentiment and expectation gaps on stock prices before policies are implemented.

  • Industry/Sector Analysis Framework

    Vertical Integration and Regulatory Unbundling Analysis

    Analyzing the pros and cons of vertically integrated business models involving insurance, PBMs, and providers in the healthcare industry, and assessing the restructuring impact of antitrust or mandatory unbundling regulations on synergies and valuation logic.

  • Industry/Sector Analysis Framework

    Payer-Provider Risk Transfer Mechanism

    Analyzing how changes in Medicaid and ACA subsidy policies affect the number of uninsured individuals, thereby altering hospital bad debt risks and insurer risk pool quality, which is a key micro-mechanism for understanding fluctuations in healthcare service performance.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Centene (CNC.US)
    Beneficiary
    Strengths
    Focused on Medicaid and Marketplace plans, directly benefiting from restored ACA subsidies and stable Medicaid funding
    Comparison
    Higher policy sensitivity compared to diversified MCOs
    Risks
    Policy compromise falls short of expectations
  • Molina Healthcare (MOH.US)
    Beneficiary
    Strengths
    Similar to CNC, pure-play Medicaid name with high elasticity from risk pool improvement
  • HCA Healthcare (HCA.US)
    Beneficiary
    Strengths
    Reduction in uninsured patients will directly lower bad debt expenses, improving margins
    Weaknesses
    Current stock price has not fully reflected this expectation
  • UnitedHealth Group (UNH.US)
    Long-term Beneficiary/Short-term Volatility
    Strengths
    Businesses like Optum Health are industry leaders even if independent, strong resistance to regulatory unbundling
    Weaknesses
    Restricted vertical integration may bring short-term restructuring costs and valuation re-rating
    Comparison
    More resilient than ELV and CVS
    Risks
    Loss of synergies due to forced unbundling
  • Cigna (CI.US)
    Relative Beneficiary
    Strengths
    Specialty pharmacy business can add value independently, PBM policy risks have cleared
  • Elevance Health (ELV.US)
    Negatively Impacted
    Weaknesses
    Value-based care businesses (CarelonRx, etc.) rely on cross-selling with insurance operations, competitiveness declines after separation
    Comparison
    Disadvantaged compared to UNH
    Risks
    Tightening vertical integration regulations
  • CVS Health (CVS.US)
    Negatively Impacted
    Weaknesses
    Highly dependent on integration between retail clinics and insurance, faces high unbundling pressure and risk of lost synergies
    Risks
    Regulatory forced unbundling

Key data

  • Trump Approval Rating40.2%As of the report release, slightly lower than during the same period of his first term
  • House Control PredictionDemocratic Win Probability ~75-82%Based on prediction market data such as Polymarket
  • Senate Control PredictionRepublicans Slightly Favored (Kalshi shows 57%)Outcome is close, with uncertainty
  • Medicare Advantage Penetration Rate~55%Proportion of total Medicare enrollment, significantly higher than during early reform debates
  • Uninsured Rate ForecastMay rise to 9%+ by 2028If current policies continue; Democratic goal is to restore it to around 5%
  • UNH Target Price$492Rating: Outperform
  • CNC Target Price$68Rating: Outperform
  • HCA Target Price$413Rating: Market-Perform

Impact & implications

The report believes that the midterm election results will directly reshape the stability of the healthcare payment environment. Democrats regaining the House will provide a policy floor for Medicaid insurers and hospitals, reducing downside performance risks. For investors, attention should be paid to allocation opportunities in Medicaid-related names in the short term. In the medium to long term, around the 2028 election, regulatory noise surrounding vertical integration may increase, leading to heightened volatility in the stock prices of large integrated healthcare groups. Investors need to be wary of business models that rely on internal synergies rather than standalone competitiveness (such as some value-based care providers) and focus on companies that can maintain industry leadership even after business separations (such as UNH, CI).

Risks

  • Deviation of election results from predictions (e.g., Republicans unexpectedly retaining the House)
  • Insufficient bipartisan compromise leading to policy gridlock
  • Emergence of radical Medicare for All candidates in the 2028 election causing severe market volatility
  • Uncertainty regarding the specific implementation methods of vertical integration regulatory policies

What to watch

  • Final seat results of the November 2026 midterm elections
  • Specific healthcare bill drafts proposed by Democrats in the House (particularly regarding Medicaid and ACA subsidies)
  • Whether medical policy compromise clauses are included in the 2027 debt ceiling negotiations
  • Healthcare policy platforms of 2028 presidential primary candidates (particularly statements on vertical integration)
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins